Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ: OPRX )

14.21 +0.65 (+4.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 150,416
Open 13.45
Bid (Size) 14.08 (1)
Ask (Size) 15.00 (1)
Prev. Close 13.56
Today's Range 13.45 - 14.68
52wk Range 11.59 - 30.82
Shares Outstanding 17,618,607
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods. 
Via Benzinga
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
From OptimizeRx Corporation
Via GlobeNewswire

Performance

YTD
-17.00%
-17.00%
1 Month
-5.46%
-5.46%
3 Month
-19.35%
-19.35%
6 Month
-28.27%
-28.27%
1 Year
-44.45%
-44.45%

More News

Read More
Recap: OptimizeRx Q1 Earnings
Via Benzinga
OptimizeRx Earnings Preview
Via Benzinga
A Preview Of OptimizeRx's Earnings
Via Benzinga
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Reports First Quarter 2023 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
From OptimizeRx Corporation
Via GlobeNewswire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
OptimizeRx Authorizes $15 Million Share Repurchase Program
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Earnings Scheduled For March 8, 2023
Via Benzinga
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.